申请人:Ray Nicholas Charles
公开号:US20120277275A1
公开(公告)日:2012-11-01
Compounds of formula (I) are useful in the treatment of diseases where enhanced M3 receptor activation is implicated, such as respiratory tract diseases:
式(I)的化合物在治疗呼吸道疾病等需要增强M3受体激活的疾病中很有用。